Abiopharma

🔍 HORIZON KINETICS ASSET MANAGEMENT LLC (Executive)

Company: RENN Fund, Inc. (RCG)

Report Date: 2026-08-21

Detailed Transactions and Holdings:

• Acquired 756 shares of Common Stock at $2.87 per share (Direct)
  Date: 2026-08-21 | Code: P | equity_swap_involved: 0 | shares_owned_after: 956,100.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Horizon Kinetics Asset Management LLC, a Delaware limited liability company and wholly owned subsidiary of Horizon Kinetics Holding Corporation, serves as the investment adviser to the Issuer and has a pecuniary interest in shares held in various accounts that it manages.